Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on TreatmentNerea Vega‐García, Mireia Camós, Margarita Ortega et al.|Frontiers in Pediatrics|2021Cited by 9
Is acute lymphoblastic leukemia with mature B-cell phenotype and <i>KMT2A</i> rearrangements a new entity? A systematic review and meta-analysisGloria Hidalgo‐Gómez, Margarita Ortega, Carlos Palacio et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 5
How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemia Gloria Hidalgo‐Gómez, Margarita Ortega, Bárbara Tazón‐Vega et al.|Annals of Hematology|2025Cited by 5